|
Contact
information:
Telephone: (514) 340-8222, ext.
5530
e-mail address:
michael.pollak@mcgill.ca
website: http://www.mcgill.ca/pollak-lab/
http://www.medicine.mcgill.ca/oncology/displayoncology.asp?Oncology_ID=25
Projects for Thesis
Supervision:
1. Any projects related to peptide growth
factors and neoplasia.
Recent
Publications:
Venkateswara, V., Haddad, A.Q.,
Fleshner, N.E., Fan, R., Sugar, L.M., Nam, R., Klotz, L.H. and
Pollak, M. (2007)
Association of diet-induced hyperinsulinemia with accelerated growth of
prostate cancer (LNCaP) xenografts. J. Natl. Cancer Inst. 99: 1793-1800.
Raina, K., Blouin, M.J., Singh, R.P., Majeed,
N., Deep, G., Varghese, L., Glodé, L.M., Greenberg, N.M., Hwang, D.,
Cohen, P., Pollak, M.N. and
Agarwal, R. Dietary feeding of silibnin inhibits prostate tumor
growth and progression in transgenic adenocarcinoma of the mouse
prostate model. Cancer Res. 67: 11083-11091.
Dowling, R.J., Zakikhani, M.,
Fantus, I.G., Pollak, M. and
Sonenberg, N. (2007)
Metformin inhibits mammalian target of rapamycin-dependent translation
initiation in breast cancer cells. Cancer Res. 67: 10804-10812.
|
